GlassScriptPhysician profile
Spero Demoleas
NPI 1295776755
$10,171.18
in general payments reported to CMS, 2019-2025
31 companies · $2,098 in 2025
The $2,098 reported for 2025 was more than what 84% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $975 · 2020: $392 · 2021: $1,890 · 2022: $1,164 · 2023: $1,349 · 2024: $2,303 · 2025: $2,098.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,751.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,750.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $2,181.14 | 2021-2025 | |
| Stryker Corporation | $1,523.55 | 2021-2025 | Citrefix, Infinity Adaptis, Infinity |
| Smith+Nephew, INC. | $1,170.73 | 2019-2025 | Grafix Pl, Oasis, Stravix Pl |
| Kerecis Limited | $846.26 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Integra Lifesciences Corporation | $424.41 | 2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Paratek Pharmaceuticals, INC. | $418.12 | 2022-2025 | Nuzyra |
| Amgen INC. | $414.83 | 2024-2025 | Krystexxa |
| Zimmer Biomet Holdings, INC. | $409.33 | 2019-2022 | |
| Abbott Laboratories | $366.78 | 2019-2023 | Diamondback Peripheral, Proclaim |
| Organogenesis INC. | $340.07 | 2019-2023 | Affinity |
| Convatec INC. | $310.39 | 2023-2024 | |
| Royal Biologics, INC. | $248.98 | 2020-2022 | |
| Paragon 28, INC. | $203.77 | 2022-2025 | Hammertube Sterile Implant Kits |
| Next Science LLC | $175.25 | 2023-2024 | Blastx, Xperience, Surgx |
| Biocomposites INC | $143.18 | 2025 | Stimulan |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $125.00 | 2019 | |
| Osiris Therapeutics INC. | $122.28 | 2019 | |
| Abbvie INC. | $121.55 | 2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $121.17 | 2019-2021 | |
| Urgo Medical North America, LLC | $117.94 | 2023 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Stability Biologics, LLC | $107.62 | 2023 | |
| Boston Scientific Corporation | $63.13 | 2019 | |
| Seapearl East, INC | $59.95 | 2023-2025 | |
| Fidia Pharma USA INC. | $35.00 | 2019 | |
| Medshape, INC. | $31.56 | 2023 | Dynaclip Bone Fixation System, Quattro, 22mm X 20mm X 20mm |
| Orpyx Medical Technologies US INC. | $23.15 | 2023 | Orpyx Si |
| Polarityte, INC. | $22.79 | 2019 | |
| Medtronic, INC. | $18.13 | 2023 | Venaseal |
| Grt US Holding, INC. | $13.02 | 2022 | |
| Horizon Therapeutics Plc | $11.93 | 2020 | |
| Musculoskeletal Transplant Foundation INC. | $0.17 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Spero Demoleas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.